p53 expression and apoptosis in melanomas of dogs and cats.
Twenty-seven melanocytic tumours from 20 dogs and four cats were examined for p53 expression and apoptosis. They included tumours that were histologically classified as benign (BM), primary malignant (PMM) and metastatic malignant melanomas (MMM). For all cases clinical follow-up was available. p53 expression was examined immunohistochemically using different monoclonal and polyclonal antibodies. Apoptosis was detected using the TUNEL technique. The tissue sections were analysed using a quantitative image analysing system. A p53 index (p53I) and an apoptotic index (AI) were determined. p53 over-expression was found infrequently in these canine and feline melanocytic tumours. Apoptosis was observed in some of the malignant tumours. In one feline case of malignant melanoma, p53 accumulation together with apoptosis was seen in three metastases but not in the primary tumour. p53I and AI were not significantly correlated with survival. These results are similar to those reported for human cutaneous melanomas.
Roels
S
S
Section of Pathology, Department of Biocontrol, Veterinary and Agrochemical Research Centre (VAR), Groeselenberg 99, B-1180, Brussels, Belgium. stroe@var.fgov.be
Tilmant
K
K
Ducatelle
R
R
D000818:Animals; D017209:Apoptosis; D014408:Biomarkers, Tumor; D001706:Biopsy / Q000662:veterinary; D002371:Cat Diseases / Q000503:physiopathology*; D002415:Cats; D018450:Disease Progression; D004283:Dog Diseases / Q000503:physiopathology*; D004285:Dogs; D020287:In Situ Nick-End Labeling / Q000662:veterinary; D008543:Melanins / Q000032:analysis; D008545:Melanoma / Q000503:physiopathology / Q000662:veterinary*; D015996:Survival Rate; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis*
D014408:Biomarkers, Tumor; D008543:Melanins; D016159:Tumor Suppressor Protein p53